mingming Liu

Prof. mingming Liu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2014 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
QWQingbin Wu
Qingbin Wu
YJYingli Jing
Yingli Jing
XYXiaochen Yuan
Xiaochen Yuan
XZXiaoyan Zhang
Xiaoyan Zhang
BLBingwei Li
Bingwei Li
RXRuijuan Xiu
Ruijuan Xiu

1 February 2014 in Thyroid®
Verified
Journal Article
Closed access
JZJing Zhang
Jing Zhang
LZLanlan Zhao
Lanlan Zhao
YGYing Gao
Ying Gao
MLmingming Liu
mingming Liu
TLTing Li
Ting Li
BSBingyin Shi
Bingyin Shi
Background: Hashimoto's thyroiditis (HT) is a common organ-specific autoimmune disease. Antithyroglobulin antibodies (TgAb) and antithyroperoxidase antibodies (TPOAb), predominantly of the immunoglobulin (Ig) G class, are hallmarks of HT. It has been reported that HT can be divided into IgG4 and non-IgG4 thyroiditis. The aim of our study was to investigate the meaning of this classification. Methods: Thyroid sections from 53 Hashimoto's patients with stored serum samples were collected to detect IgG4, IgG, α-smooth muscle actin, and transforming growth factor-β1 expression by immunohistochemical staining. The degree of fibrosis of thyroid parenchyma was qualitatively evaluated by Masson's trichrome. Serum total IgG, IgG4, TPOAb IgG, TgAb IgG, TPOAb IgG4, and TgAb IgG4 were detected by enzyme-linked immunosorbent assays (ELISAs). Results: Based on immunohistochemistry for IgG4 and IgG, 12 cases of IgG4-positive HT and 41 cases of IgG4-negative HT were identified in our study. The patients in the IgG4-positive HT group were significantly younger than those in the IgG4-negative HT group ( p =0.023), and no significant differences were found in sex distribution, disease duration, and distribution of thyroid functional status between these two groups. The degree of fibrosis evaluated by Masson's trichrome and the immunohistochemical expression score of TGF-β1 in the IgG4-positive HT were significantly higher than those in the IgG4-negative HT ( p <0.05). No significant differences were found in the levels of serum IgG4, total IgG, or IgG4/IgG ratio. However, TPOAb IgG4 and TgAb IgG4 levels and the ratios of TPOAb IgG4/TPOAb IgG, TgAb IgG4/TgAb IgG, TPOAb IgG4/IgG4, and TgAb IgG4/IgG4 were significantly higher in the IgG4-positive HT group than those in the IgG4-negative HT group respectively ( p <0.05). Conclusions: Our study indicates that HT can be divided into IgG4-positive and IgG4-negative HT, and this classification might have important clinical implications. The levels of IgG4 binding to specific thyroid antigens might be noninvasive markers to differentiate these two different immunophenotypes.

12 April 2016 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
FSFei Shang
Fei Shang
MLmingming Liu
mingming Liu
BLBingwei Li
Bingwei Li
XZXiaoyan Zhang
Xiaoyan Zhang
YSYouming Sheng
Youming Sheng
RXRuijuan Xiu
Ruijuan Xiu

16 August 2024 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
YWYingyu Wang
Yingyu Wang
BWBing Wang
Bing Wang
HLHao Ling
Hao Ling
YLYuan Li
Yuan Li
SFSunjing Fu
Sunjing Fu
MLmingming Liu
mingming Liu
Coronary microvascular dysfunction (CMD) refers to structural and functional abnormalities of the microcirculation that impair myocardial perfusion. CMD plays a pivotal role in numerous cardiovascular diseases, including myocardial ischemia with non-obstructive coronary arteries, heart failure, and acute coronary syndromes. This review summarizes recent advances in CMD pathophysiology, assessment, and treatment strategies, as well as ongoing challenges and future research directions. Signaling pathways implicated in CMD pathogenesis include adenosine monophosphate-activated protein kinase/Krüppel-like factor 2/endothelial nitric oxide synthase (AMPK/KLF2/eNOS), nuclear factor erythroid 2-related factor 2/antioxidant response element (Nrf2/ARE), Angiotensin II (Ang II), endothelin-1 (ET-1), RhoA/Rho kinase, and insulin signaling. Dysregulation of these pathways leads to endothelial dysfunction, the hallmark of CMD. Treatment strategies aim to reduce myocardial oxygen demand, improve microcirculatory function, and restore endothelial homeostasis through mechanisms including vasodilation, anti-inflammation, and antioxidant effects. Traditional Chinese medicine (TCM) compounds exhibit therapeutic potential through multi-targeted actions. Small molecules and regenerative approaches offer precision therapies. However, challenges remain in translating findings to clinical practice and developing effective pharmacotherapies. Integration of engineering with medicine through microfabrication, tissue engineering and AI presents opportunities to advance the diagnosis, prediction, and treatment of CMD.

1 April 2013 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
LZLanlan Zhao
Lanlan Zhao
MLmingming Liu
mingming Liu
YGYing Gao
Ying Gao
YHYouyuan Huang
Youyuan Huang
GLGuizhi Lu
Guizhi Lu
BSBingyin Shi
Bingyin Shi
Objective: Thyroglobulin antibody (TgAb) is an important autoantibody in thyroid diseases, which is a glycoprotein, predominantly of IgG class. Glycosylation of the IgG-Fc contributes to many effector functions exhibited by antibodies. The aim of our study was to investigate the glycosylation of sera TgAb in patients with different thyroid diseases.Design and methods: Sera from 146 patients were collected and divided into four groups: Hashimoto's thyroiditis (HT, n=90), Graves' disease (GD, n=20), papillary thyroid carcinoma (PTC, n=17), and PTC with histological lymphocytic thyroiditis (PTC-T, n=19). HT patients were further divided into euthyroidism and subclinical and overt hypothyroidism groups. Lectin-ELISAs were performed to detect the relative amount of core fucose, terminal galactose, and sialic acid on each TgAb respectively.Results: Among HT, GD, and PTC groups, HT patients had significantly lower core fucose content on TgAb than the other two groups; an increasing trend of sialylation was found in PTC sera (P=0.076) compared with HT groups. PTC-T patients had significantly higher sialylated TgAb than HT and GD patients, and no significant difference was found between PTC and PTC-T. There was no significant difference in the three carbohydrate residue contents on sera TgAb among HT subgroups. In all the patients, negative correlation was found between sialic acid content and TgAb IgG levels (r=−0.736, P<0.001).Conclusions: Our study showed that glycosylation of sera TgAb varied in different thyroid diseases and it might be involved in pathogenesis of thyroid disorders.

1 February 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YZYong-Gang Zhao
Yong-Gang Zhao
FMFan-Xing Meng
Fan-Xing Meng
BLBingwei Li
Bingwei Li
YSYou-Ming Sheng
You-Ming Sheng
MLmingming Liu
mingming Liu
RXRui-Juan Xiu
Rui-Juan Xiu